TrialThe lancet. Gastroenterology & hepatology2017

Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies.

Gautam Goel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.